» Authors » Manjunath Ramanjaneya

Manjunath Ramanjaneya

Explore the profile of Manjunath Ramanjaneya including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 722
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Alser M, Ramanjaneya M, Anwardeen N, Donati F, Botre F, Jerobin J, et al.
Rev Cardiovasc Med . 2024 Jul; 23(5):181. PMID: 39077591
Background: Humanin and the mitochondrial open reading frame of the 12S rRNA-c (MOTS-c) are mitochondrial encoded peptides involved in energy metabolism, cytoprotection, longevity, insulin sensitivity and their expression decrease with...
2.
Jerobin J, Ali R, Khalil S, Ramanjaneya M, Betahi I, Abou Samra A, et al.
Qatar Med J . 2023 Nov; 2023(2):20. PMID: 38025335
Chronic Urticaria (CU) is a complex skin disease that appears as recurrent raised itchy rash/angioedema or both for more than six weeks. The pathophysiology of CU is complex and has...
3.
Antonisamy B, Shailesh H, Hani Y, Ahmed L, Noor S, Ahmed S, et al.
Metabolites . 2023 Nov; 13(11). PMID: 37999242
Asthma and obesity are two of the most common chronic conditions in children and adolescents. There is increasing evidence that sphingolipid metabolism is altered in childhood asthma and is linked...
4.
Butler A, Ramanjaneya M, Moin A, Hunt S, Atkin S
Front Endocrinol (Lausanne) . 2023 Oct; 14:1228853. PMID: 37810875
Background: A 12-year study comparing clinical outcomes following Roux-en-Y bariatric surgery showed long-term weight loss with remission/prevention of type-2-diabetes (T2D), hypertension and dyslipidemia. However, it is unknown whether the underlying...
5.
Benjamin S, Ramanjaneya M, Butler A, Janjua I, Paramba F, Palaki J, et al.
Front Clin Diabetes Healthc . 2023 Mar; 2:733693. PMID: 36994321
Introduction: SGLT-2 inhibitors are shown to be nephroprotective, slowing progression of nonalcoholic steatohepatitis (NASH) in addition to improving glycemic control in patients with type 2 diabetes (T2D). To date, no...
6.
Bettahi I, Krishnankutty R, Jaganjac M, Suleiman N, Ramanjaneya M, Jerobin J, et al.
Front Endocrinol (Lausanne) . 2023 Mar; 13:1024832. PMID: 36876056
Background: Skeletal muscle is the main site for insulin-dependent glucose disposal. The hyperinsulinemic euglycemic clamp (HIEC) is the gold standard for the assessment of insulin sensitivity (IS). We have previously...
7.
Ramanjaneya M, Bettahi I, Pawar K, Halabi N, Moin A, Sathyapalan T, et al.
Int J Mol Sci . 2022 Dec; 23(23). PMID: 36499023
Hypoglycemia, as a complication of type 2 diabetes (T2D), causes increased morbidity and mortality but the physiological response underlying hypoglycemia has not been fully elucidated. Small noncoding microRNA (miRNA) have...
8.
Ramanjaneya M, Priyanka R, Bensila M, Jerobin J, Pawar K, Sathyapalan T, et al.
Front Endocrinol (Lausanne) . 2022 Aug; 13:917041. PMID: 36017315
Objective: Hypoglycemia in type 2 diabetes (T2D) increases morbidity and mortality but the underlying physiological response is still not fully understood, though physiological changes are still apparent 24 hours after...
9.
Ramanjaneya M, Diboun I, Rizwana N, Dajani Y, Ahmed L, Butler A, et al.
Front Endocrinol (Lausanne) . 2022 Aug; 13:918320. PMID: 35909516
Introduction: Complement factors mediate the recruitment and activation of immune cells and are associated with metabolic changes during pregnancy. The aim of this study was to determine whether complement factors...
10.
Mohammed-Ali R, Jerobin J, Khalil S, Sivaraman S, Ramanjaneya M, Betahi I, et al.
Qatar Med J . 2022 Aug; 2022(2):5. PMID: 35909395
Chronic urticaria (CU) is a common and complex disorder that occurs without any identifiable provoking factor. The mechanisms underlying CU pathogenesis are still not fully understood. The autoimmune theory of...